Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-014434
Filing Date
2025-06-10
Accepted
2025-06-10 07:12:56
Documents
1
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3187
  Complete submission text file 0001641172-25-014434.txt   4582
Mailing Address 50 SEALY DRIVE LAWRENCE NY 11559
Business Address
Weichselbaum Alan (Reporting) CIK: 0001435390 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41952 | Film No.: 251035932

Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)